ATS 2026 showcased new pulmonary therapies, clinical trials, and cross-specialty collaboration to improve patient care.
Jerry A. Krishnan, MD, PhD
Advertisement
Jerry A. Krishnan, MD, PhD, is the associate vice chancellor for population health sciences at the University of Illinois Chicago.
Articles by Jerry A. Krishnan, MD, PhD
Jerry A. Krishnan, MD, PhD, discusses NIH RECOVER findings on long COVID, pulmonary complications, and immune dysfunction at ATS 2026.
RECOVER Initiative findings highlighted the heterogeneity of long COVID symptoms and mechanisms in diverse patient populations.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss
2
Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year
3
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
4
Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD
5